AI Visibility Scorecard
EGFR Inhibitors in lung cancer
techblessing.com · Healthcare
Borderline visible. AI bots can crawl EGFR Inhibitors in lung cancer, but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.
AI engines read this profile 2 times
Claude
#827,099 of 923,499 in Healthcare for AI visibility
51
AI Naming Predictability
iSometimes named · 51/100
4
AEO Visibility
iNear-invisible · 3.5/10
5
Muse Index Score
iAI agent readiness
Basic · 5/100
0
AI Adoption
iNone detected · 0/100
About EGFR Inhibitors in lung cancer
from our crawl and measurement
"Methods == We performed a genome-wide affiliation study of 770 children with sJIA collected in nine countries by the Worldwide Childhood Joint disease Genetics Range." That is how EGFR Inhibitors in lung cancer introduces itself. When AI engines look at it, they find little to work with. It scores 3.5 out of 10.
Our crawl found a sitemap and a readable heading structure. It is missing structured data describing the business and an llms.txt file.
AI crawlers have visited once in our tracking, including ClaudeBot (Anthropic).
The 6 signals AI reads
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Good
Clear headings and answer-style content.
Entity Clarity
Weak
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Weak
Experience, Expertise, Authority, Trust markers.
Technical AEO
Fair
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Fair
Sitemaps and entity links AI can follow.
Off-page authority
How the web signals your brand to AI
Backlinks
Weak
No inbound links found yet.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 3.5/10, EGFR Inhibitors in lung cancer is crawlable but under-signaled - fixable, and the signals above are where to start.
Is this your brand?
The exact fixes for EGFR Inhibitors in lung cancer
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for EGFR Inhibitors in lung cancer.
Source & Attribution
Scored by Engagemii on August 7, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/techblessing
Cite this score: Engagemii (2026). "AEO Score for EGFR Inhibitors in lung cancer." Retrieved from https://engagemii.com/aeo/brands/techblessing
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform